Institute for Research, Development and Innovation (IRDI) of the International Medical University (IMU), Malaysia
The Institute for Research, Development and Innovation (IRDI) of the International Medical University (IMU), Malaysia, was established on 18 September 2012, as part of the strategic plans of the university to realign its research direction. The Institute consists of two major arms, namely, the Research and Development Arm and Commercialisation and Support Arm. There are four Centres of Excellence (CoE) based on the identified thrust areas, namely the Centre for Environmental and Population Health, Centre for Bioactive Molecules and Drug Discovery, Centre for Cancer and Stem Cell Research and Centre for Health Professional Education Research. The CoE have developed strategies to excel in the thrust areas and to be more competitive in bidding for external funds. The CoE will tap into the diverse expertise of our researchers and develop strategic partnerships with local and foreign institutions. In parallel with this development, the Commercialisation and Support Arm has come up with strategies to promote commercialisation of our research products and services and to provide training and services to enhance the capability of our researchers. Through the establishment of IRDI, IMU aspires to bring research to a higher level.
KeywordsStem Cell Research Bioactive Molecule Industrial Partner Strategic Partnership Medical Education Research
- 3.Chu WL (2013) Research at IMU: achievements, thrust areas and future challenges. IeJSME 7(Suppl 1):S7–S18Google Scholar
- 4.Chu WL, Lim YW, Radhakrishnan AK, Lim PE (2010) Protective effect of aqueous extract from Spirulina platensis against cell death induced by free radicals. BMC Compl Alter Med 10:53Google Scholar
- 5.Hla YY, Babar MG, Mitha S, Zuhanariah Mohd Nordin (2012) Medical education research 2000–2011. International Medical University, 171 pGoogle Scholar
- 9.Poh YW, Gan SY, Tan EL (2012) Effects of Il-6, Il-10 and Tgf-Β on the expression of survivin and apoptosis in nasopharyngeal carcinoma TwO1 cells. Exp Oncol (Online) 34(2):85–89Google Scholar
- 10.Voon PT, Ng TKW, Lee VKM, Nesaretnam K (2011) Diets rich in palmitic acid (16:0), lauric and myristic acids (12:0 + 14:0), or oleic acid (18:1) do not alter postprandial or fasting plasma homocysteine and inflammatory markers in healthy Malaysian adults. Am J Clin Nutr 94(6):1451–1457CrossRefGoogle Scholar